Category:Hedgehog pathway inhibitors

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved.


This category has only the following subcategory.

Pages in category "Hedgehog pathway inhibitors"

The following 3 pages are in this category, out of 3 total.